Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Huntington’s Disease: Complex Pathogenesis and Therapeutic Strategies
Huichun Tong, Tianqi Yang, Shuying Xu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3845-3845
Open Access | Times Cited: 20

Showing 20 citing articles:

Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence
Enzo Pereira de Lima, Lucas Fornari Laurindo, Vitor Cavallari Strozze Catharin, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 124-124
Open Access | Times Cited: 5
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease
Alaa Shafie, Amal Adnan Ashour, Saleha Anwar, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 6, pp. 571-595
Closed Access | Times Cited: 9
Advances in Stem Cell Therapy for Huntington’s Disease: A Comprehensive Literature Review
Siddharth Shah, Hadeel M. Mansour, Brandon Lucke‐Wold
Cells (2025) Vol. 14, Iss. 1, pp. 42-42
Open Access | Times Cited: 1
Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington’s Disease
Yousef Tizabi, Samia Bennani, Nacer El Kouhen, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1144-1144
Open Access | Times Cited: 6
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
Asif Ahmad Bhat, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 6
Emerging biophysical techniques for probing synaptic transmission in neurodegenerative disorders
Mayur B. Kale, Nitu L. Wankhede, Ashok Kumar Bishoyi, et al.
Neuroscience (2024) Vol. 565, pp. 63-79
Closed Access | Times Cited: 6
Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives
Ching‐Pang Chang, Ching-Wen Wu, Yijuang Chern
Neurobiology of Disease (2024), pp. 106672-106672
Open Access | Times Cited: 4
Advances in Understanding Biomarkers and Treating Neurological Diseases -Role of the Cerebellar Dysfunction and Emerging Therapies
Azhagu Madhavan Sivalingam
Ageing Research Reviews (2024), pp. 102519-102519
Closed Access | Times Cited: 4
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 4
Intellectual Property Rights in Neuroprotective Biomaterials
Chandrabhan Prajapati, Prabhash Nath Tripathi, Saloni Sood, et al.
(2025), pp. 251-269
Closed Access
The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases
Lian Jin, L. S. Nie, Yan Deng, et al.
Cell Proliferation (2025)
Open Access
Natural products in neurodegenerative diseases: recent advances and future outlook
Lutfun Nahar, Rawiwan Charoensup, Kulyash Kalieva, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review
Neserin Ali, Usman Sayeed, Syed Monowar Alam Shahid, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Thymoquinone-loaded solid lipid nanoparticles mitigate 3-Nitropropionic acid-induced mitochondrial dysfunction and oxidative damage via regulating PGC-1α/Nrf2 pathway
Surekha Ramachandran, Thangarajan Sumathi
NeuroToxicology (2025) Vol. 108, pp. 191-205
Closed Access
Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications
Nurzhan Abdukarimov, Kamilya Kokabi, Jeannette Kunz
Antioxidants (2025) Vol. 14, Iss. 5, pp. 527-527
Open Access
Resveratrol: A Natural Compound Targeting the PI3K/Akt/mTOR Pathway in Neurological Diseases
Biswajit Kumar Utpal, Fatima Zohra Mokhfi, Mehrukh Zehravi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders
Kanchan Bala, Pratyush Porel, Khadga Raj Aran
Psychopharmacology (2024)
Closed Access | Times Cited: 2
Inflammasomes in neurodegenerative diseases
Qianchen Wang, Songwei Yang, Xuan Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Heavy Metals Interactions with Neuroglia and Gut Microbiota: Implications for Huntington’s Disease
Yousef Tizabi, Samia Bennani, Nacer El Kouhen, et al.
(2024)
Open Access | Times Cited: 1
Identification of pivotal genes and pathways in Chorea-acanthocytosis using comprehensive bioinformatic analysis
Ravinder Sharma, Kiran Yadav, Leeza Monga, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0309594-e0309594
Open Access
Enfermedad de Huntington: Un abordaje desde lo celular y lo fisiológico
Nicolás David Avella Malaver, Cristian Felipe García Rubio, María Alejandra Castellanos Suárez, et al.
Revista Salud Bosque (2022) Vol. 14, Iss. 2
Open Access
Page 1

Scroll to top